Video
Lynlee Burton, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, discusses how the pandemic has impacted the way the United States views the pharmacist within the immunization space.
Pharmacy Times interviewed Lynlee Burton, MBA, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, on the significance of short vaccine development timelines for the future of COVID-19 vaccine development.
During the interview, Burton discussed the value of the pharmacist in administering vaccines during the COVID-19 pandemic and how the pandemic has shifted the nation’s perspective on the role of the pharmacist in immunizations.